HighGravityData
Companies / Humana / Filing

Humana — Nov 5, 2025 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000055
Open on SEC.gov ↗
Showing in the filing
Change in year-end medical membership - Group Medicare Advantage
“Relatively flat”
Period
FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 25
GAAP EPS for FY2025
“approximately $12.26”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Individual Medicare Advantage membership (de… for FY2025
“approximately 425,000 members”
Adjusted FY 2025 EPS for FY2025
“approximately $17.00”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $17.00”
Diluted EPS - Non-GAAP for FY2025
“approximately $17.00”
Diluted EPS - GAAP for FY2025
“approximately $12.26”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $12.26”
Total Revenues Consolidated - GAAP for FY2025
“at least $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“at least $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“at least $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of approximately 425,000”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth of approximately 160,000”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.6% to 12.1%”
Operating Cost Ratio - Consolidated Non-GAAP for FY2025
“11.3% to 11.7%”
Insurance segment income from operations - G… for FY2025
“$1.6 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.1 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.3 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 20.0%”
Effective Tax Rate - Non-GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Insurance segment no change GAAP: at least $123 billion CenterWell segment no change GAAP: at least $21.5 billion Change in year-end medical membership from prior year-end Individual Medicare Advantage Decline of approximately 425,000 Decline of 'up to 500,000' Group Medicare Advantage no change Relatively flat Medicare stand-alone PDP no change Growth of approximately 200,000 State-based contracts Growth of approximately 160,000 Growth within 175,000 to 250,000 range State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, Virginia, and Wisconsin. Benefit Ratio  Insurance segment no change GAAP: 90.1% to 90.5% Ratio calculation: benefits expense as a percent of premiums revenues. Operating Cost Ratio Consolidated GAAP: 11.6% to 12.1% Non-GAAP: 11.3% to 11.7% GAAP: 11.3% to 11.7% Ratio calculation: operating costs excluding depreciation and amortization as a percent of revenues excluding investment income. Due to charges incurred to date and charges that could potentially be recorded related to the company's ongoing value creation and other strategic initiatives, the company anticipates potential changes to its FY 2025 GAAP ratio. Segment Results Insurance segment income from operations no change GAAP: $1.6 billion to $2.0 billion   CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization. CenterWell segment income from operations no change GAAP:
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.